BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19628875)

  • 1. Structure of signal-regulatory protein alpha: a link to antigen receptor evolution.
    Hatherley D; Graham SC; Harlos K; Stuart DI; Barclay AN
    J Biol Chem; 2009 Sep; 284(39):26613-9. PubMed ID: 19628875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors.
    Hatherley D; Harlos K; Dunlop DC; Stuart DI; Barclay AN
    J Biol Chem; 2007 May; 282(19):14567-75. PubMed ID: 17369261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.
    Hatherley D; Graham SC; Turner J; Harlos K; Stuart DI; Barclay AN
    Mol Cell; 2008 Jul; 31(2):266-77. PubMed ID: 18657508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47.
    Hatherley D; Lea SM; Johnson S; Barclay AN
    J Biol Chem; 2014 Apr; 289(14):10024-8. PubMed ID: 24550402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein α (SIRPα), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein β (SIRPβ).
    Fournier B; Andargachew R; Robin AZ; Laur O; Voelker DR; Lee WY; Weber D; Parkos CA
    J Biol Chem; 2012 Jun; 287(23):19386-98. PubMed ID: 22511785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47.
    Lee WY; Weber DA; Laur O; Stowell SR; McCall I; Andargachew R; Cummings RD; Parkos CA
    J Biol Chem; 2010 Dec; 285(49):37953-63. PubMed ID: 20826801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
    Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
    J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site.
    Subramanian S; Boder ET; Discher DE
    J Biol Chem; 2007 Jan; 282(3):1805-18. PubMed ID: 17098740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of signal regulatory protein gamma (SIRPγ) in complex with an antibody Fab fragment.
    Nettleship JE; Ren J; Scott DJ; Rahman N; Hatherley D; Zhao Y; Stuart DI; Barclay AN; Owens RJ
    BMC Struct Biol; 2013 Jul; 13():13. PubMed ID: 23826770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel structural determinants on SIRP alpha that mediate binding to CD47.
    Lee WY; Weber DA; Laur O; Severson EA; McCall I; Jen RP; Chin AC; Wu T; Gernert KM; Parkos CA
    J Immunol; 2007 Dec; 179(11):7741-50. PubMed ID: 18025220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
    Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
    J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
    Miller TW; Amason JD; Garcin ED; Lamy L; Dranchak PK; Macarthur R; Braisted J; Rubin JS; Burgess TL; Farrell CL; Roberts DD; Inglese J
    PLoS One; 2019; 14(7):e0218897. PubMed ID: 31276567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein
    Wang Z; Hu N; Li X; Wang H; Ren C; Qiao C; Chen G; Wang J; Zhou L; Wu J; Zhang D; Feng J; Shen B; Peng H; Luo L
    Mol Pharmacol; 2021 Sep; 100(3):193-202. PubMed ID: 34315811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.
    Matozaki T; Murata Y; Okazawa H; Ohnishi H
    Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis.
    Wu Z; Weng L; Zhang T; Tian H; Fang L; Teng H; Zhang W; Gao J; Hao Y; Li Y; Zhou H; Wang P
    Cell Res; 2019 Jun; 29(6):502-505. PubMed ID: 31089204
    [No Abstract]   [Full Text] [Related]  

  • 18. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
    Liu Y; O'Connor MB; Mandell KJ; Zen K; Ullrich A; Bühring HJ; Parkos CA
    J Immunol; 2004 Feb; 172(4):2578-85. PubMed ID: 14764731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.
    Zhang W; Huang Q; Xiao W; Zhao Y; Pi J; Xu H; Zhao H; Xu J; Evans CE; Jin H
    Front Immunol; 2020; 11():18. PubMed ID: 32082311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity-- implications for engraftment of human cells.
    Kwong LS; Brown MH; Barclay AN; Hatherley D
    Immunology; 2014 Sep; 143(1):61-7. PubMed ID: 24786312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.